New York Academy of Medicine
Mitchell Blutt, MD, is a pioneer in the private healthcare sector, the first doctor to successfully transition from practicing clinical medicine to a role as a professional healthcare investor. Now serving as CEO of Consonance Capital in New York City, Mitchell Blutt, MD is involved in a number of health-related organizations, including the New York Academy of Medicine.
For 22 years, the New York Academy of Medicine has awarded the Rudin Glaucoma Prize to physicians and researchers who demonstrate excellence in studying glaucoma as evidenced by their high-level contributions to peer-reviewed scientific journals. For the 2017 calendar year, the academy chose Mary Kelly, PhD, of Oregon Health & Science University as its winner, recognizing her paper titled, “Induced Pluripotent Stem Cells Restore Function in a Human Cell Loss Model of Open-Angle Glaucoma.”
The groundbreaking research discussed in this article is the first to show that stem cells can be used to deal with the baseline biological causes of glaucoma. Standard treatment manages the symptoms, but the use of stem cells could potentially give doctors a way to reverse the condition instead.
Rock ‘n’ Roll Marathon Series
The first physician to launch a successful career in the healthcare investment sector, Mitchell invests in healthcare companies as the founder of Consonance Capital in New York. Mitchell Blutt also formerly served on the board of directors for the Michael J. Fox Foundation, which welcomes members of the public to contribute toward finding a cure for Parkinson’s by joining Team Fox for athletic events such as the 2017 Rock ‘n’ Roll Marathon Series.
The Rock ‘n’ Roll Marathon Series began with the simple idea of a marathon with bands positioned along the course to cheer on participants. Celebrating its 20th year, the event has grown into a nationwide series of marathons consisting of a weekend of entertainment and runs to support participating charities. The world-class Health and Fitness Expo takes place alongside the marathon. The event concludes with a concert featuring big name musical performers.
Team Fox will participate in two upcoming marathons in the 2017 Rock n’ Roll Series: one in Brooklyn, New York, on October 14 and one in San Antonio, Texas, on December 2 through December 3. Runners who become a member of Team Fox will receive guaranteed entry into the race, running singlet for race day, and a personal fundraising page. Runners must commit to a specific fundraising goal based on race participation and those who meet their goal will receive a commemorative medal.
Addiction Speaker Series
Mitchell Blutt, MD, is CEO and founder of Consonance Capital , a healthcare investment firm based in New York City. Dr. Mitchell Blutt also serves as a clinical assistant professor at Weill Cornell Medical College and is a former member of the advisory board for CASA, The National Center on Addiction and Substance Abuse.
CASA, founded in 1992, strives to “connect science with policy and practice” in the field of addiction and substance abuse, with the ultimate goal of improving the lives of those afflicted both directly and indirectly by this destructive illness.
To date, CASA researchers have published more than 200 articles on substance abuse and addiction. In addition, the organization is dedicated to keeping the public informed on the importance of preventing substance use by children, and the misunderstood nature of addiction, which is often seen as a choice rather than an illness. CASA also highlights nationwide shortcomings such as the mere two cents of every dollar of federal spending received each year for addiction prevention and treatment.
The organization’s Addiction Speaker Series brings in experts whose talks on topics as diverse as “Digital Interventions to Reduce Problem Substance Use” and “Adolescent Substance Misuse Prevention” are available both live at CASA’s New York office, and as webinars. The series is free but the live events require registration.
Bridging the Gap
A pioneer in the healthcare investment business, Dr. Mitchell Blutt founded Consonance Capital in 2005 and leads the firm as chief executive officer. Mitchell Blutt began his medical career by earning his doctor of medicine from the University of Pennsylvania Perelman School of Medicine, which participates in community outreach through the Bridging the Gaps program.
Founded in 1991, the Bridging the Gaps (BTG) program draws students from a diverse array of disciplines attending the University of Pennsylvania, Philadelphia College of Osteopathic Medicine, Drexel University, Temple University, and Thomas Jefferson University. One of the main components of the program is the Community Health Internship Program (BTG CHIP).
Through the BTG CHIP Program, students engage in a paid summer internship through which they gain insight into the complex factors that impact the health of individuals in economically disadvantaged communities. Additionally, the program gives students a unique opportunity to collaborate across disciplines.
The BTG CHIP Program places students in some 100 nonprofit organizations in Pennsylvania and New Jersey. Students work in teams alongside site staff members and faculty to create projects that both meet the needs of community members and further students’ knowledge in their areas of academic interest. To learn more about the BTG CHIP program, visit http://www.med.upenn.edu/btg.